Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

Presentation TCT 2025

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Presenter: Donald Cutlip

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

Presentation TCT 2025

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

Presenter: Donald Cutlip

October 26, 2025

Presentation TCT 2024

REC/CAGE FREE

Presenter: Donald Cutlip

October 30, 2024

Presentation TCT 2023

SELUTION DCB

Presenter: Donald Cutlip

October 25, 2023

Presentation TCT 2023

Status Quo on SELUTION4ISR & SELUTION4DeNovo

Presenter: Donald Cutlip

October 24, 2023

Presentation TCT 2022

When Do I Use Mechanical Support for Left Main PCI?

Presenter: Donald Cutlip

September 18, 2022

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Donald Cutlip

September 21, 2018

Presentation TCT 2017

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Donald Cutlip

October 30, 2017

Presentation TCT 2016

LEADERS FREE: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Donald Cutlip

October 31, 2016

Presentation TCT 2016

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Presenter: Donald Cutlip, Christian Hengstenberg, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Presenter: Donald Cutlip, Christian Hengstenberg, Sigmund Silber

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

News Conference News TCT 2015

Very Late Stent Thrombosis Remains an Important Clinical Target

October 12, 2015

Presentation TCT 2015

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Presenter: Robert A. Byrne, Stefan K. James, Donald Cutlip

October 11, 2015

Presentation TCT 2014

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Louis B. Jacques

September 15, 2014

Presentation TCT 2014

Regulation of Cardiovascular Devices in Europe: A Need for Change

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Angeles Alonso Garcia

September 15, 2014

Presentation TCT 2014

Impact of the Affordable Care Act on Innovation: Effects of the New Reimbursement Climate Change

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Jack C. Lewin

September 15, 2014

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

REC/CAGE FREE

SELUTION DCB

Status Quo on SELUTION4ISR & SELUTION4DeNovo

When Do I Use Mechanical Support for Left Main PCI?

The Methods for Coronary Stent Development

Emerging Thromboresistant BMS 1: Cobra PzF Stents

LEADERS FREE: Pros and Cons

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Very Late Stent Thrombosis Remains an Important Clinical Target

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Regulation of Cardiovascular Devices in Europe: A Need for Change

Impact of the Affordable Care Act on Innovation: Effects of the New Reimbursement Climate Change

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content